UK pharmacy-led retailer Boots has launched Foundayo, a once-daily oral weight-loss treatment containing GLP-1 drug orforglipron, through Boots Online Doctor and selected outlets. Prices start at GBP79.20 for eligible new customers. Boots said 67% of customers accessing weight-loss medication since its July Wegovy tablet launch were new to the service, while 47% of new customers chose Wegovy. Dedicated weight-management spaces are available in more than 220 stores. (Boots)